The prime factor for insufficient surfactant production and pulmonary immaturity is birth of a new-born before reaching the term. Objectives: The current study is to estimate the effect of antenatal steroid administration to women before anticipated preterm labor and to assess the importance of corticosteroids for preventing neonatal mortality due to preterm birth complications. Materials and Methods: A prospective observational study on women at high risk of preterm delivery between 24 and 37 weeks of gestation were included in the study and Pregnancies complicated by congenital anomalies, chromosomal abnormalities, or multifetal gestation and women expected to deliver in less than 12 hr for any reason was excluded. Results: Eighteen women (90%) received betamethasone and two (10%) received dexamethasone. Fifteen women (75%) received a complete course of antenatal steroids; five (25%) woman received one of a planned two-dose course of betamethasone. The most common reason for exclusion was the expectation that delivery would occur within 24 hr which was determined in 8 of 30 women who did not meet the eligibility criteria. Length of hospital stay for most of the infants was between 3-5 days but few discharged after 5 days. The discharged days were extended due to feeding problem. Conclusion: In this study we concluded that betamethasone was the most common antenatal steroid prescribed among the steroids to women before anticipated preterm labor and also we found that with the use of antenatal steroids at the right time, the neonatal death rates can be reduced.
INTRODUCTION
Labor before 37 weeks of gestation defined as preterm birth is the main determinant of postnatal mortality and morbidity. 1 The incidence of preterm birth in the developed world is between 7-12%. 2 Respiratory Distress Syndrome (RDS), also known as hyaline membrane disease was the primary cause of morbidity and mortality in preterm new-born. 1 Maturation of foetal lungs is dependent on surfactant, which is a complex molecule. The prime factor for insufficient surfactant production and pulmonary immaturity is birth of a newborn before reaching the term. 2 Antenatal steroid treatment for women who are at risk of preterm delivery has emerged as the most effective intervention for the prevention of RDS, reducing early neonatal mortality and morbidity. 3 Corticosteroids act by promoting the expressions of proteins that accelerate the functional and structural maturity of pulmonary cells and other organs. The physiological effects on the lungs result from the production of proteins and enzymes involved in the production of phospholipids by type 2 pneumocytes. The physiological effects include improvement of pulmonary expansion, reduction in vascular permeability, improvement of respiratory function and response to postnatal surfactants. 4 The National Institutes of Health (NIH) sponsored a Consensus Development Conference on the effect of corticosteroids for fetal lung maturation on perinatal outcomes, concluding that a single course of corticosteroids should be considered for women at risk of preterm delivery. It concluded that the optimal benefit of corticosteroids lasted for 7 days and further research was needed to determine the possible benefit of repeat corticosteroid doses 7 days after the initial course. 5
Objectives of the study
The objective of the current study is to estimate the effect of antenatal steroid administration to women before anticipated preterm labor and to assess the importance of corticosteroids for preventing neonatal mortality due to preterm birth complications.
MATERIALS AND METHODS
A prospective observational study was carried out for a period of two months in the gynecology department of a tertiary care hospital at Tamil Nadu. Women at high risk of preterm delivery between 24 and 37 weeks of gestation were included in the study. Pregnancies complicated by congenital anomalies, chromosomal abnormalities, or multifetal gestation and women expected to deliver in less than 12 h for any reason was excluded from the study. The source of data was patient case notes and medication charts.
RESULTS AND DISCUSSION

Characteristics of the Participants
Of the 30 charts screened of women, 20 pregnant women met inclusion criteria and had been treated with antenatal corticosteroids. The most prevalent gestational age was less than or equal to 34 weeks and 6 day of gestation (75%). The maternal age of the patient was found to be between 25-30 years (65%) and observing the gravidity (60%) were of primigravida. The method of delivery of the womens receiving antenatal steroids was cesarean section (95%) and time taken for delivery was 24-48 hr 12 patients (60%) and 48 hr-7 days was 8 patients (40%) ( Table 1) .
Eighteen women (90%) received betamethasone and two (10%) received dexamethasone (Figure 1 ).
Fifteen women (75%) received a complete course of antenatal steroids; five (25%) woman received one of a planned two-dose courses of betamethasone. The most common reason for exclusion was the expectation that delivery would occur within 24 h which was determined in 8 of 30 women who did not meet the eligibility criteria
Neonatal Outcome
There were no stillbirths or neonatal deaths within 72 hr. The rate of the composite outcome of severe respiratory complications was lower in the neonates of betamethasone received antenatal women's.
The rates of the respiratory distress syndrome (35%), apnea (35%), pneumonia and transient tachypnea of the newborn (5%) were significantly lower in the in the neonates of betamethasone received antenatal women, there was also a lower rate of resuscitation at birth (40%) and surfactant use (30%) (Table 2 and Figure 2 ).
Length of hospital stay for most of the infants was between 3-5 days but few discharged after 5 days. The discharged days were extended due to feeding problem (Table 3 ). 
CONCLUSION
In this study we concluded that betamethasone was the most common antenatal steroid prescribed among the steroids to women before anticipated preterm labor and also, we found that with the use of antenatal steroids at the right time, the neonatal death rates can be reduced. Further studies are required to optimize the use of antenatal corticosteroids.
